Correlates and predictors of colorectal cancer screening among male automotive workers

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 3, 2007, Pages 500-509

  McQueen, Amy ^a   Vernon, Sally W ^a   Myers, Ronald E ^c   Watts, Beatty G ^b   Eun, Sul Lee ^a   Tilley, Barbara C ^d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PREDICTOR VARIABLE; PRIORITY JOURNAL; SELF CONCEPT; SOCIAL PSYCHOLOGY;

ATTITUDE TO HEALTH; AUTOMOBILES; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; HUMANS; INTENTION; LINEAR MODELS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; OCCUPATIONS; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS;

EID: 34047256717     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0757     Document Type: Article

References (87)

1. American Cancer Society. Cancer facts and figures, 2006. Atlanta (GA): American Cancer Society; 2006.
2. Winawer SJ, Zauber AG, Ho MN, et al.; The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
3. U S. Preventive Services Task Force Screening for colorectal cancer: recommendations and rationale. Ann Intern Med 2002;137:129-31.
4. Meissner HI, Breen NL, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the US. Cancer Epidemiol Biomarkers Prev 2006;15:389-94.
5. Swan J, Breen NL, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
6. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med 2003;36:85-91.
7. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population: results from the 2000 National Health Interview Survey. Cancer 2004;100:2093-103.
8. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21:132-7.
9. Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin Colon Rectal Surg 2000;11: 58-72.
10. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.
11. Myers RE, Track BJ, Lerman CL, Wolf TA, Ross EA, Engstrom PF. Adherence to colorectal cancer screening in an HMO population. Prev Med 1990;19:502-14.
12. Tilley BC, Vernon SW, Myers RE, et al. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev Med 1999;28: 276-83.
13. Myers RE, Ross EA, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-51.
14. Myers RE, Vernon SW, Tilley BC, Lu M, Watts BG. Intention to screen for colorectal cancer among white male employees. Prev Med 1998;27: 279-87.
15. Watts BG, Vernon SW, Myers RE, Tilley BC. Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev 2003;12:339-49.
16. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78:471-9.
17. Myers RE, Chodak GW, Wolf TA, et al. Adherence by African American men to prostate cancer education and early detection. Cancer 1999;86:88-104.
18. Sutton SR, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 2000;7: 99-104.
19. Gritz ER, Bastani R. Cancer prevention - behavior changes: the short and long of it. Prev Med 1993;22:676-88.
20. Rothman AJ. Toward a theory-based analysis of behavioral medicine. Health Psychol 2000;19:64-9.
21. Robinson CR, Waxweiler RJ, McCammon CS. Pattern and model makers, proportional mortality 1972-1978. Am J Ind Med 1980;1:159-65.
22. Swanson FM, Belle SH, Burrows RW. Colon cancer incidence among modelmakers and patternmakers in the automobile manufacturing industry. J Occup Med 1985;27:567-9.
23. Tilley BC, Vernon SW, Glanz K, et al. Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial. Prev Med 1997;26:227-35.
24. Tilley BC, Glanz K, Kristal AR, et al. Nutrition intervention for high-risk auto workers: results of the Next Step Trial. Prev Med 1999;28:284-92.
25. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev 1997;6:825-32.
26. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc.; 2000.
27. Cohen J. A power primer. Psychological Bulletin 1992;112:155-9.
28. Bastani R, Maxwell AE, Bradford C. Cross-sectional versus prospective predictors of screening mammography. Cancer Epidemiol Biomarkers Prev 1996;5:845-8.
29. Vernon SW. Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr 1999;(25):101-19.
30. Aiken LS, West SG, Woodward CK, Reno RR, Reynolds KD. Increasing screening mammography in asymptomatic women: evaluation of a second-generation, theory-based program. Health Psychol 1994;13:526-38.
31. Codori A-M, Petersen GM, Miglioretti DL, Boyd PA. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 2001;33:128-36.
32. Lemon SC, Zapka JG, Puleo E, Luckmann R, Chasan-Taber L. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001;91:1264-72.
33. Abrams DB, Boutwell WB, Grizzle J, Heimendinger J, Sorensen G, Varnes J. Cancer control at the workplace: the Working Well Trial. Prev Med 1994;23: 15-27.
34. Heimendinger J, Feng Z, Emmons KM, et al.; The Working Well research group. The Working Well Trial: baseline dietary and smoking behaviors of employees and related worksite characteristics. Prev Med 1995;24:180-93.
35. Levy MC. Correlates of cancer-preventive nutrition practices in a worksite population. Los Angeles (CA): University of California Los Angeles; 1994.
36. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
37. Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2005;14:2855-61.
38. Farrands PA, Hardcastle JD, Chamberlain JO, Moss SM. Factors affecting compliance with screening for colorectal cancer. Community Med 1984;6: 12-9.
39. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98: 2082-91.
40. Chao A, Connell CJ, Cokkinides V, Jacobs EJ, Calle EE, Thun MJ. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health 2004;94:1775-81.
41. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med 2002;23:28-35.
42. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med 2003;36:659-68.
43. Walsh JME, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev Med 2002;35:209-18.
44. Straus WL, Mansley EC, Gold KF, Wang Q, Reddy P, Pashos C. Colorectal cancer screening attitudes and practices in the general population: a risk-adjusted survey. J Public Health Manag Pract 2005;11:244-51.
45. Etzioni DR, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 California health interview survey. Cancer 2004;101:2523-32.
46. Gorin SS, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med 2005;40:515-26.
47. Brawarsky P, Brooks DR, Mucci LA, Wood PA. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev 2004;28:260-8.
48. MacRae FA, Hill DJ, St. John DJB, Ambikapathy A, Garner JF. Predicting colon cancer screening behavior from health beliefs. Prev Med 1984;13:115-26.
49. Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med 1995;41:365-74.
50. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 2003;37:627-34.
51. Juon H, Han W, Shin H, Kim KB, Kim MT. Predictors of older Korean Americans' participation in colorectal cancer screening. J Cancer Educ 2003; 18:37-42.
52. Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev Med 1990;19:562-74.
53. Greiner KA, James AS, Born WK, et al. Colorectal cancer screening preferences and predictors of Fecal Occult Blood Test (FOBT) return among low income adults. Prev Med 2005;41:676-84.
54. Paskett ED, D'Agostino RB, Jr., Tatum CM, Velez R, Brenes GA. Colorectal cancer screening practices among low-income women. Clin J Women's Health 2000;1:3-9.
55. Menon U, Champion VL, Larkin GN, Zollinger TW, Gerde PM, Vernon SW. Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program. J Occup Environ Med 2003;45:891.
56. Weinberg DS, Turner BJ, Wang H, Myers RE, Miller SM. A survey of women regarding factors affecting colorectal cancer screening compliance. Prev Med 2004;38:669-75.
57. Price JH. Perceptions of colorectal cancer in a socioeconomically disadvantaged population. J Community Health 1993;18:347-62.
58. Gorin SS. Correlates of colorectal cancer screening compliance among urban Hispanics. J Behav Med 2005;28:125-37.
59. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med 2000;31:410-6.
60. Paskett ED, Rushing J, D'Agostino RB, Jr., Tatum CM. Cancer screening behaviors of low-income women: the impact of race. Women Health 1997;3: 203-26.
61. Sun WY, Basch CE, Wolf RL, Li XJ. Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med 2004;39:323-9.
62. Rawl SR, Champion VL, Menon U, Skinner CS. Validation of scales to measure benefits and barriers to colorectal cancer screening: scale development. J Psychosocial Oncol 2001;19:47-63.
63. Lewis SF, Jensen NM. Screening sigmoidoscopy: factors associated with utilization. J Gen Intern Med 1996;11:542-4.
64. Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients. Am J Prev Med 2003;25:187-94.
65. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002;11:529-34.
66. Manne SL, Markowitz A, Winawer SJ, et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 2002;21:3-15.
67. Stockwell DH, Woo P, Jacobsen BC, et al. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol 2003; 98:1875-80.
68. Hoogewerf PE, Hislop TG, Morrison BJ, Burns SD, Sizto R. Health belief and compliance with screening for fecal occult blood. Soc Sci Med 1990;30: 721-6.
69. Halper MS, Winawer SJ, Brody RS, Andrews M, Roth D, Burton G. Issues of patient compliance. In: Winawer SJ, Schottenfeld D, editors. Colorectal cancer: prevention, epidemiology, and screening. New York (NY): Raven Press; 1980. p. 299-310.
70. Weller DP, Owen N, Hiller JE, Willson K, Wilson D. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health 1995;19:18-23.
71. Kelly RB, Shank JC. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med Care 1992;30:1029-42.
72. Farraye FA, Wong M, Hurwitz S, et al. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol 2004;99:341-9.
73. Harewood GC, Wiersema MJ, Melton LJ III. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002;97:3186-94.
74. DeVellis BM, Blalock SJ, Sandler RS. Predicting participation in cancer screening: the role of perceived behavioral control. J Applied Soc Psychology 1990;20:639-60.
75. Kremers SPJ, Mesters I, Pladdet IE, Van den Borne B, Stockbrugger RW. Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol Biomarkers Prev 2000;9:1127-30.
76. Honda K. Factors associated with colorectal cancer screening among the U S. urban Japanese population. Am J Public Health 2004;94:815-22.
77. Costanza ME, Luckmann R, Stoddard AM, et al. Applying a stage model of behavior change to colon cancer screening. Prev Med 2005;41: 707-19.
78. Friedman LC, Webb JA, Richards CS, Plon SE. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-25.
79. Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation of high-risk subjects in colon cancer screening. Cancer 1989;63:2211-5.
80. Powe BD. Fatalism among elderly African Americans: effects on colorectal cancer screening. Cancer Nurs 1995;18:385-92.
81. Sarna L, Chang BL. Colon cancer screening among older women caregivers. Cancer Nurs 2000;23:109-16.
82. Kinney AY, Bloor LE, Martin C, Sandler RS. Social ties and colorectal cancer screening among blacks and whites in North Carolina. Cancer Epidemiol Biomarkers Prev 2005;14:182-9.
83. Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev 1997;6:44-52.
84. Tang TS, Solomon LJ, McCracken LM. Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract 2001;9:277-82.
85. Taylor VM, Lessler D, Mertens K, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc 2003;95:806-12.
86. Greiner KA, Engelman KK, Hall MA, Ellerbeck EF. Barriers to colorectal cancer screening in rural primary care. Prev Med 2004;38:269-75.
87. Morales LS, Rogowski J, Freedman VA, Wickstrom SL, Adams JL, Escarce JJ. Sociodemographic differences in use of preventive services by women enrolled in Meidcare+Choice plans. Prev Med 2004;39: 738-45.